Santen Pharmaceutical Co., Ltd.
4536.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥8 | ¥6 | ¥9 | ¥9 |
| Dep. & Amort. | ¥5 | ¥4 | ¥4 | ¥5 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥8 | -¥2 | ¥2 | ¥2 |
| Other Non-Cash | ¥1 | -¥1 | ¥4 | -¥2 |
| Operating Cash Flow | ¥6 | ¥8 | ¥19 | ¥14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥7 | -¥2 | -¥3 | -¥4 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | -¥0 | ¥0 | -¥2 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥3 | ¥1 |
| Other Inv. Act. | ¥0 | -¥0 | -¥0 | -¥0 |
| Investing Cash Flow | -¥7 | -¥2 | -¥1 | -¥3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥0 | -¥1 | ¥0 | ¥0 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥20 | -¥8 | ¥0 | -¥14 |
| Dividends Paid | -¥0 | -¥6 | -¥0 | -¥6 |
| Other Fin. Act. | -¥1 | -¥0 | -¥1 | -¥1 |
| Financing Cash Flow | -¥21 | -¥15 | -¥1 | -¥20 |
| Forex Effect | ¥1 | ¥1 | -¥2 | ¥3 |
| Net Chg. in Cash | -¥21 | -¥8 | ¥15 | -¥7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥85 | ¥93 | ¥78 | ¥84 |
| End Cash | ¥64 | ¥85 | ¥93 | ¥78 |
| Free Cash Flow | ¥4 | ¥6 | ¥18 | ¥11 |